Programmed cell death 1 (PD-1) is an important target for immune checkpoint inhibitor therapies that block its signaling and boost T-cell activity. PD-1 inhibitors have been approved for treating various…

When Ben Brown, research assistant professor of chemistry, thinks about the opioid epidemic, he views the problem on a molecular level.

A new study that contributes additional data to a growing body of evidence demonstrating disparities in restraint use in the emergency department (ED) has been published in the January issue…

Montana lawmakers are in a standoff with the state's health department over a package of sweeping changes to child care licensing rules that includes a disputed provision to allow religious…

There are approximately 425 million people worldwide with diabetes. Approximately 75 million of these inject themselves with insulin daily.

A groundbreaking study conducted by Professor Jiyoung Park and her research team in the Department of Biological Sciences at UNIST has identified FAM3C, a metabolism-regulating signaling molecule produced by cancer-associated…

Researchers from Miami Cancer Institute, part of Baptist Health South Florida, today published a study in Trends in Cancer that analyzes the use of tissue-agnostic therapeutics in patients with primary…

Think of a time when you had two different but similar experiences in a short period. Maybe you attended two holiday parties in the same week or gave two presentations…

This content originally appeared on Everyday Health. Republished with permission.A large new study suggests that Ozempic and Wegovy don’t increase the risk of suicidal thoughts, a potential side effect that has…

A McGill-led team of researchers have made an important discovery shedding light on the genetic basis of a rare skeletal disorder.